ÂÜÀòÂÒÂ×

Dale Porter possesses extensive experience in oncology and immuno-oncology research, currently serving as the Vice President and Head of U.S. Oncology & Immuno-Oncology Research at Servier. Previously, Dale held the position of Vice President of Biology at Cedilla Therapeutics. Other notable roles include Director at the Broad Institute of MIT and Harvard, Director of Oncology Translational Research at Novartis, and various senior research investigator positions at Novartis. Dale began a research career as a post-doctoral fellow at Dana-Farber Cancer Institute. Education includes a Bachelor of Science and a PhD from Cornell University, completed between 1991 and 2000.